Advocacy & Policy

HHS and 15 other federal departments and agencies issued an interim final rule to delay the implementation of the revised “the Common Rule” for six months.

—Three research and industry institutions Nov. 14 testified before the Senate Health, Education, Labor, and Pensions (HELP) Committee about the role of gene edi

House and Senate negotiators Nov. 8 agreed to remove language in the National Defense Authorization Act (NDAA) for fiscal year (FY) 2018 that would restrict the

The AAMC and four other higher education associations Nov. 6 sent a letter to Environmental Protection Agency (EPA) Administrator Scott Pruitt opposing a new po

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors met Oct. 30 to approve funding for a $9 million new study comparing two approaches t

The AAMC submitted comments to two committees of the National Academies of Sciences, Engineering, and Medicine (NASEM) in response to the committees’ request fo

The Senate Sept. 18 advanced an amended version of H.R. 2810, the National Defense Authorization Act for Fiscal Year 2018 (NDAA) by a vote of 89-8.

The AAMC joined over 100 organizations on a letter expressing support for a research-related bipartisan amendment to the FY 2018 National Defense Authorization.

Department of Health and Human Services Secretary Tom Price, MD, appointed Brenda Fitzgerald, MD, as the Centers for Disease Control and Prevention director.

The AAMC submitted a letter to the FDA in response to FDA’s request for comments on the agency’s efforts “to enhance future patient engagement."